Drugs / Cell-Cultured Smallpox Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00042094 | Mar 2002 → Mar 2003 | smallpox | DynPort Vaccine Company LLC, A GDIT Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cell-Cultured Smallpox Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00042094 ↗ |
| Known as | CCSV | “a Cell-Cultured Smallpox Vaccine (CCSV) Compared to a Calf Lymph Vaccine (Dryvax®)” NCT00042094 ↗ |
| Modality | Vaccine | “Cell-Cultured Smallpox Vaccine” NCT00042094 ↗ |